The Menlo Park-based company is building a service for quick at-home health services, such as lab draws and Covid-19 testing. The company is looking to build the “DoorDash for lab draws,” raising $33 million from backers.
The Food and Drug Administration granted an emergency use authorization for an at-home Covid-19 and flu test kit by Labcorp. It uses a test that was developed by Roche and authorized last year.
The diagnostics company opened on the Nasdaq on Friday, trading for $20 per share. It’s now trading at $18.63 per share.
The call to action is that point-of-care testing needs to move to the home and it needs to be supported by a Medicaid or Medicare billing code to support insurance coverage and payment for the testing.
The at-home testing startup plans to launch a broader virtual care offering after raising $150 million in funding. It plans to roll out virtual visits and offer prescription medications, in addition to building out its array of tests.
Covid-19 has renewed interest in diagnostics and a way to deliver care at home. Learn from companies and experts as they address the future of these two developments.
After insurers were mandated to cover at-home Covid-19 tests, more people tested at-home screenings for other conditions. As preventive tests declined significantly during the pandemic, insurers also turned to creative means to give people access.
After the Food and Drug Administration authorized a swathe of over-the-counter tests for Covid-19, pharmacies are preparing to stock their shelves. But at $20 to $100 a pop, will enough people use them to make a difference?
After a busy year, at-home testing company Everlywell is growing through two acquisitions. It bought telehealth practice PWNHealth and another at-home lab testing company.
As Covid-19 joins the ranks of cancer and chronic diseases to be tracked and prevented through testing, health plans will need testing solutions that can be distributed quickly and at scale.
After Everlywell received an emergency use authorization last year from the FDA for its at-home collection kit, the agency gave Everlywell the green light to sell its test kits without requiring a prescription.
Ellume, whose at-home Covid-19 test was cleared by the FDA in December, got a $232 million contract from the Department of Health and Human Services to deliver 8.5 million tests.
Few people question whether care delivery will continue to migrate out of the hospital into new settings such as the home. The better question is, what services – specifically – will migrate to the home, and what innovations are necessary to support these migrations?
During a panel discussion at the J.P. Morgan Healthcare Conference, three physicians from Stanford Medicine discussed the investment opportunities that can help accelerate innovation in healthcare in the coming year.
The Austin-based startup has distributed more than 500,000 Covid-19 test kits to date, and expects total sales to quadruple by the end of the year.
The retailer is offering at-home Covid-19 testing kits, including nasal swabs and saliva test kits, from Los Angeles-based startup myLab Box.